In heterogeneous catalysis, the catalyst is in a different phase from the reactants. COA of Formula: C9H6BrN, At least one of the reactants interacts with the solid surface in a physical process called adsorption in such a way. 1532-97-4, name is 4-Bromoisoquinoline. In an article，Which mentioned a new discovery about 1532-97-4
The present invention relates to the treatment of dopamine-related dysfunction using full D1 dopamine receptor agonists in an intermittent dosing protocol with a short, but essential, ?off-period.? The D1 agonist concentration is reduced during the ?off-period? to obtain a plasma concentration of agonist that suboptimally activates D1 dopamine receptors for a period of time to prevent induction of tolerance. Specifically, the method comprises the steps of periodically administering to a patient a full D1 agonist with a half-life of up to about 6 hours at a dose resulting in a first plasma concentration of agonist capable of activating D1 dopamine receptors to produce a therapeutic effect. The dose is reduced at least once every 24 hours to obtain a second lower plasma concentration of agonist that results in suboptimal activation of D1 dopamine receptors for a period of time sufficient to prevent induction of tolerance.
I hope this article can help some friends in scientific research. I am very proud of our efforts over the past few months and hope to 1532-97-4, help many people in the next few years.COA of Formula: C9H6BrN
Reference：
Isoquinoline – Wikipedia,
Isoquinoline | C9H7N – PubChem